通过FGF4抑制ERRγ-CYP2E1通路可以减轻与酒精有关的肝损伤

Luyao Wang1,2, Wenliya Dong1, Lei Fan1,2

  • 1State Key Laboratory of Macromolecular Drugs and Large-scale Preparation, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

Hepatology (Baltimore, Md.)
|February 26, 2025
PubMed
概括

纤维细胞生长因子4 (FGF4) 在与酒精有关的肝病 (ALD) 中被上调,并通过降低ERRγ.恶化肝损伤. 准FGF4可能为ALD提供新的治疗方法.